Salesforce Eyes 89.3% EPS Growth, Halts Heroku, Launches AcuityMD App
Salesforce is projected to deliver 89.3% EPS growth with a 7.5% free cash flow yield and 56.3% analyst upside after embedding AI throughout its CRM platform. The company has halted new feature development on Heroku and introduced an AcuityMD integration on AppExchange to enhance its enterprise offering.
1. AI Exposure Ranking
Salesforce is ranked among the top three enterprise software companies for AI exposure, with analysts forecasting 89.3% EPS growth, a 7.5% free cash flow yield and 56.3% upside potential based on its AI-powered CRM enhancements.
2. Heroku Development Halted
The company has discontinued new feature development on its Heroku platform, shifting to sustaining engineering and reallocating R&D efforts towards its core CRM and AI-driven products.
3. AcuityMD AppExchange Launch
AcuityMD for Salesforce is now available on Salesforce AppExchange, enabling commercial teams to integrate AI-powered data insights directly into Salesforce workflows to identify opportunities and accelerate sales cycles.